Key facts
- This page summarizes Michael Singer's Form 4 filing for Cartesian Therapeutics, Inc. (RNAC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2026, 16:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027.
Footnote F2
Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.
Footnote F3
Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of the trust.
Footnote F4
Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of the trust.
Footnote F5
Shares are held by the reporting person's spouse.
Footnote F6
The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian.
Footnote F7
The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.